Loading company…
Relief Cardiovascular is developing a closed-loop implant for people with heart failure.
Relief Cardiovascular is developing a transcatheter implant intended to address blood flow problems associated with congestive heart failure. It targets hospitals and heart specialists treating the condition. The company is based in Costa Mesa, US. In January 2025, it raised USD 12 million in Series A funding to advance the system toward an initial human clinical trial.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in